Showing results (131-140 of 198) with videos related to
Sort By:
Pageof 20
American Journal of Preventive Medicine|November 7, 2023
Self-Sampling for Human Papillomavirus Testing: Acceptability in a U.S. Safety Net Health SystemSusan L Parker, Trisha L Amboree, Shaun Bulsara, et al.Molecular Cancer Therapeutics|September 4, 2025
Co-Targeting BCL-xL with MCL-1 Induces Lethal Mitochondrial Dysfunction in Diffuse MesotheliomaYuan Xu, Cristian G Medina, Deborah R Surman, et al.Breast Cancer Research : BCR|November 30, 2011
Different mechanisms for resistance to trastuzumab versus lapatinib in HER2-positive breast cancers--role of estrogen receptor and HER2 reactivationYen-Chao Wang, Gladys Morrison, Ryan Gillihan, et al.Breast Cancer Research and Treatment|April 22, 2008
Molecular profiles of progesterone receptor loss in human breast tumorsChad J Creighton, C Kent Osborne, Marc J van de Vijver, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 12, 2014
Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancerMatthew D Burstein, Anna Tsimelzon, Graham M Poage, et al.Genome Medicine|October 16, 2014
Obtaining informed consent for clinical tumor and germline exome sequencing of newly diagnosed childhood cancer patientsSarah Scollon, Katie Bergstrom, Robin A Kerstein, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 26, 2011
To share or not to share: a randomized trial of consent for data sharing in genome researchAmy L McGuire, Jill M Oliver, Melody J Slashinski, et al.Nature Communications|August 8, 2014
Recurrent ESR1-CCDC170 rearrangements in an aggressive subset of oestrogen receptor-positive breast cancersJamunarani Veeraraghavan, Ying Tan, Xi-Xi Cao, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2005
Patterns of resistance and incomplete response to docetaxel by gene expression profiling in breast cancer patientsJenny C Chang, Eric C Wooten, Anna Tsimelzon, et al.Breast Cancer Research : BCR|June 24, 2010
Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancerChad J Creighton, Xiaoyong Fu, Bryan T Hennessy, et al.Pageof 20